Eli Lilly to Lower Insulin Prices, Cap Patient Costs at $35/Month
- March 03, 2023
Eli Lilly and Company announced March 1 that, effective immediately, it will cap patient out-of-pocket costs for insulin at $35 or less per month.
ARTICLE TAGS
You must be logged in to access this content.